Skip to main content

Peer Review reports

From: A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer

Original Submission
20 Mar 2006 Submitted Original manuscript
29 Mar 2006 Reviewed Reviewer Report - Andrew Ko
2 Apr 2006 Reviewed Reviewer Report - Henry Xiong
14 Apr 2006 Reviewed Reviewer Report - Michele Reni
10 May 2006 Author responded Author comments - Jorg Kleeff
Resubmission - Version 2
10 May 2006 Submitted Manuscript version 2
25 May 2006 Reviewed Reviewer Report - Andrew Ko
25 May 2006 Reviewed Reviewer Report - Andrew Willan
31 May 2006 Reviewed Reviewer Report - Michele Reni
10 Jun 2006 Reviewed Reviewer Report - Henry Xiong
28 Jul 2006 Author responded Author comments - Jorg Kleeff
Resubmission - Version 3
28 Jul 2006 Submitted Manuscript version 3
25 Sep 2006 Reviewed Reviewer Report - Andrew Willan
6 Nov 2006 Author responded Author comments - Jorg Kleeff
Resubmission - Version 4
6 Nov 2006 Submitted Manuscript version 4
7 Dec 2006 Reviewed Reviewer Report - Andrew Willan
8 Dec 2006 Author responded Author comments - Jorg Kleeff
Resubmission - Version 5
8 Dec 2006 Submitted Manuscript version 5
8 Dec 2006 Author responded Author comments - Jorg Kleeff
Resubmission - Version 6
8 Dec 2006 Submitted Manuscript version 6
Publishing
11 Dec 2006 Editorially accepted
11 Dec 2006 Article published 10.1186/1471-2407-6-285

You can find further information about peer review here.

Back to article page